Ewing's Sarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Palbociclib + Ganitumab In Ewing Sarcoma
Conditions:   Ewing Sarcoma;   Ewing's Sarcoma Recurrent Interventions:   Drug: Palbociclib;   Drug: Ganitumab Sponsors:   Dana-Farber Cancer Institute;   1 Million 4 Anna Foundation;   Carson Sarcoma Foundation;   Teaming up to Fight Childhood Cancer;   ChemoWarrior: the eli sidler foundation;   i-ROK Foundation;   Rutledge Cancer Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials

SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients
Condition:   Ewing Sarcoma Interventions:   Drug: Trabectedin 1 MG [Yondelis];   Drug: Irinotecan;   Diagnostic Test: tumor biopsy;   Other: 3'-Deoxy-3'-18F Fluorothymidine (18F-FLT) Imaging Sponsors:   Sarcoma Alliance for Research through Collaboration;   Janssen Scientific Affairs, LLC;   National Institutes of Health (NIH);   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2019 Category: Research Source Type: clinical trials